Gilead Sciences appoints Dietmar Berger as Chief Medical Officer
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Aims to become India’s leading cancer testing company
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
Construction of the plant will commence in 2025 with first production expected to be in 2027
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Subscribe To Our Newsletter & Stay Updated